Diametric Capital’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-78,441
Closed -$72.6K 335
2023
Q2
$72.6K Buy
+78,441
New +$72.6K 0.03% 296